Please login to the form below

VPAS

This page shows the latest VPAS news and features for those working in and with pharma, biotech and healthcare.

Europe responding to gene therapy challenge, but picture remains fragmented

The new framework will build on the new UK-wide pricing agreement, the Voluntary Scheme for Branded Medicines Pricing and Access ( VPAS), and is expected to go out to industry for

Latest news

NHS England’s medicines chief: stop ‘salami slicing’ and get faster market access

Dark's arrival coincided with the signing of a new five-year Voluntary Price and Access Scheme (VPAS), which caps NHS expenditure on medicines, but also allows NHS England to agree ... mindful of that, maintaining a tough bargaining position, even though
NHS Long-term Plan welcomed – but warnings on staff and overpromising

UK pharma industry response. The new Long-term Plan coincides with the launch of a new five year Voluntary Pricing and Access Scheme (VPAS) covering branded medicines in the UK. ... He also hailed the introduction of the VPAS, saying it “should see the
New ‘voluntary’ UK pricing deal caps growth, but promises faster uptake

Decades old PPRS name to go

More from news
Approximately 0 fully matching, plus 4 partially matching documents found.

Latest Intelligence

Evolution or revolution: the latest review of NICE methods

What is not part of the review – because it’s a done deal as part of VPAS – is the basic cost- effectiveness threshold. ... Leela worked as an advisor to the Department of Health and Social Care on the 2019 Voluntary Scheme for Branded Medicines
The UK’s new medicines pricing deal – opportunities and risks for pharma

So what are the big differences between the 2014 PPRS and the 2019 VPAS? ... Overall VPAS covers more than 85% of all NHS spend on branded drugs.
The UK’s new five-year pricing agreement

The UK has a new five-year Voluntary Pricing and Access Scheme (VPAS) for branded medicines, which came into force on 1 January 2019.
Comment: the new UK pricing deal – welcome news, but lessons to be learned

Leslie Galloway, chairman of EMIG reflects on the new UK government-pharma industry pricing agreement

More from intelligence
Approximately 2 fully matching, plus 2 partially matching documents found.

Latest from PMHub

Let's be ambitious for patients and life sciences investment in Global Britain

Industry argues that the remarkable VPAS deal which caps NHS spending on medicines would cover any costs. ... A new 10-year VPAS with more substantial and defined NICE reform locked in?
Hanover Communications

Since this Pharmaceutical Industry Competitiveness Task Force report in 2005, there have been at least five UK life science strategies plus three PPRS or VPAS deals.
Volt Pharma Associates

VPA supports life sciences companies, investors and academic institutes in developing new products, technologies and innovative approaches. ... VPA’s aim is to solve our clients’ product research, development and commercialisation challenges so they

More from PMHub
Approximately 0 fully matching, plus 3 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

Client Services Director – London or Home Based – Medical Commun...: Highly Competitive Salary, Bonus &Benefits

Editor & Senior Editor - Medical Communications - Home Based: Highly Competitive Salary, Bonus &Benefits

Home Working Medical Copy Writer & Senior Medical Copy Write...: Highly Competitive Salary, Bonus &Benefits

Freelance Medical Writer - Creative Healthcare Comms - 2 month t...: Excellent Day Rate

Medical Writer, Senior Medical Writer, Principal Medical Writer,...: Highly Competitive Salary, Bonus &Benefits

Senior Account / Programme Manager - MedComms - Buckinghamshire: Highly Competitive Remuneration packages

Senior Content Editor - Biotechnology: Salary TBC

Senior Leadership Role – Medical Communications – North West: Highly Competitive Salary, Bonus &Benefits

FREELANCE Medical Writer, Senior Medical Writer, Principal Medic...: Highly Competitive Day Rate, Bonus &Benefits

Freelance Account Manager - Creative Healthcare Comms - Immediat...: Excellent Day Rate

Account Management: Competitive Salary Offered

Senior Account Director & Associate Director - Healthcare Ad...: Highly Competitive Salary, Bonus &Benefits

PMHub

Add my company

Spirit

We find the soul in the science, the humanity in the data, harnessing the power of creativity to deliver medical...

Latest intelligence

InSite Events™ National Pharma Meeting: A Customer Story: How our client leveraged Impetus Digital’s white-glove service, 360° coverage and care, and award-winning InSite Events™ platform to successfully transfer their annual national meeting online....
Fear or encouragement, which is best to drive behaviour change?: The communications industry depends on fear of the perceived loss of something, in order to create the hope found in a product benefit. But, if if left too long unchecked,...
The unheard, unseen, and uncorrected effects of COVID-19: The disproportionate effects of the pandemic have been highlighted amongst ethnic minorities, so is it likely that ethnic minorities will be more worried about participating? And could this exacerbate inequalities...